Advertisement

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement

Oct

06

Today In Oncology

Autonomous AI Triaged Urgent Suspected Skin Cancer Referrals in Real-World Implementation Study

ER-Positive HER2-Negative Advanced Breast Cancer: Giredestrant Plus Everolimus

Immune Cell Dysfunction Not Absence Defines Nonmelanoma Skin Cancer in Immunosuppressed Patients

Wildfire-Related Fine Particulate Matter Linked to Higher Mortality in Older Patients With Lung Cancer

Global Gaps in Cancer-Control Expenditure Data Identified

Advertisement

© 2026 HSP News Service, L.L.C.